APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urokinase

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Selected research

Market Analysis & Forecast

Global Urokinase Market Analysis and Forecast 2026-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchUrokinase Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Urokinase Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Urokinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urokinase Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Urokinase Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Global Urokinase (CAS 9039-53-6) main manufactuers include Syner-Med, LIVZON, Wanhua Biochem and Techpool, totally accounting for about 50% of the market. China is the largest market of Urokinase (CAS 9039-53-6), holding a share about 56%. As for the types of products, it can be divided into urokinase powder and urokinase polution. The most common type is urokinase powder, with a share about 92%. As for the applications of products, it is widely used in hospitals, clinics and others. The most common application is in hospitals, with a share about 78%.

This report presents an overview of global market for Urokinase, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Urokinase, also provides the sales of main regions and countries. Of the upcoming market potential for Urokinase, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Urokinase sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Urokinase market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Urokinase sales, projected growth trends, production technology, application and end-user industry.

Urokinase Segment by Company

Syner-Med

Wanhua Biochem

Jiangxi Haoran Bio-Pharma

Jiangsu Aidea Pharmaceutical

Techpool

Microbic Biosystems

LIVZON

Urokinase Segment by Type

Urokinase Powder

Urokinase Solution

Urokinase Segment by Application

Hospital

Clinic

Others

Urokinase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urokinase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Urokinase in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urokinase sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Urokinase Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Urokinase Powder Major Manufacturers Table 3. Urokinase Solution Major Manufacturers Table 4. Global Urokinase Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Others Major Manufacturers Table 8. Urokinase Industry Trends Table 9. Urokinase Industry Drivers Table 10. Urokinase Industry Opportunities and Challenges Table 11. Urokinase Industry Restraints Table 12. Global Urokinase Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Urokinase Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Urokinase Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Urokinase Revenue Market Share by Region (2021-2026) Table 16. Global Urokinase Revenue Market Share by Region (2027-2032) Table 17. Global Urokinase Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (BIU) Table 18. Global Urokinase Sales by Region (2021-2026) & (BIU) Table 19. Global Urokinase Sales by Region (2027-2032) & (BIU) Table 20. Global Urokinase Sales Market Share by Region (2021-2026) Table 21. Global Urokinase Sales Market Share by Region (2027-2032) Table 22. Global Urokinase Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Urokinase Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Urokinase Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Urokinase Sales Market Share by Manufacturers (2021-2026) Table 26. Global Urokinase Sales Price (US$/MIU) of Manufacturers (2021-2026) Table 27. Global Urokinase Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Urokinase Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Urokinase Manufacturers, Product Type & Application Table 30. Global Urokinase Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Urokinase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Urokinase Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Urokinase Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Urokinase Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Urokinase Revenue Market Share by Type (2021-2026) Table 37. Global Urokinase Revenue Market Share by Type (2027-2032) Table 38. Global Urokinase Sales by Type 2021 VS 2025 VS 2032 (BIU) Table 39. Global Urokinase Sales by Type (2021-2026) & (BIU) Table 40. Global Urokinase Sales by Type (2027-2032) & (BIU) Table 41. Global Urokinase Sales Market Share by Type (2021-2026) Table 42. Global Urokinase Sales Market Share by Type (2027-2032) Table 43. Global Urokinase Price by Type (2021-2026) & (US$/MIU) Table 44. Global Urokinase Price by Type (2027-2032) & (US$/MIU) Table 45. Global Urokinase Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Urokinase Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Urokinase Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Urokinase Revenue Market Share by Application (2021-2026) Table 49. Global Urokinase Revenue Market Share by Application (2027-2032) Table 50. Global Urokinase Sales by Application 2021 VS 2025 VS 2032 (BIU) Table 51. Global Urokinase Sales by Application (2021-2026) & (BIU) Table 52. Global Urokinase Sales by Application (2027-2032) & (BIU) Table 53. Global Urokinase Sales Market Share by Application (2021-2026) Table 54. Global Urokinase Sales Market Share by Application (2027-2032) Table 55. Global Urokinase Price by Application (2021-2026) & (US$/MIU) Table 56. Global Urokinase Price by Application (2027-2032) & (US$/MIU) Table 57. Syner-Med Company Information Table 58. Syner-Med Business Overview Table 59. Syner-Med Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 60. Syner-Med Urokinase Product Portfolio Table 61. Syner-Med Recent Development Table 62. Wanhua Biochem Company Information Table 63. Wanhua Biochem Business Overview Table 64. Wanhua Biochem Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 65. Wanhua Biochem Urokinase Product Portfolio Table 66. Wanhua Biochem Recent Development Table 67. Jiangxi Haoran Bio-Pharma Company Information Table 68. Jiangxi Haoran Bio-Pharma Business Overview Table 69. Jiangxi Haoran Bio-Pharma Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 70. Jiangxi Haoran Bio-Pharma Urokinase Product Portfolio Table 71. Jiangxi Haoran Bio-Pharma Recent Development Table 72. Jiangsu Aidea Pharmaceutical Company Information Table 73. Jiangsu Aidea Pharmaceutical Business Overview Table 74. Jiangsu Aidea Pharmaceutical Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 75. Jiangsu Aidea Pharmaceutical Urokinase Product Portfolio Table 76. Jiangsu Aidea Pharmaceutical Recent Development Table 77. Techpool Company Information Table 78. Techpool Business Overview Table 79. Techpool Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 80. Techpool Urokinase Product Portfolio Table 81. Techpool Recent Development Table 82. Microbic Biosystems Company Information Table 83. Microbic Biosystems Business Overview Table 84. Microbic Biosystems Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 85. Microbic Biosystems Urokinase Product Portfolio Table 86. Microbic Biosystems Recent Development Table 87. LIVZON Company Information Table 88. LIVZON Business Overview Table 89. LIVZON Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 90. LIVZON Urokinase Product Portfolio Table 91. LIVZON Recent Development Table 92. North America Urokinase Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Urokinase Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Urokinase Sales by Type (2021-2026) & (BIU) Table 95. North America Urokinase Sales by Type (2027-2032) & (BIU) Table 96. North America Urokinase Sales Price by Type (2021-2026) & (US$/MIU) Table 97. North America Urokinase Sales Price by Type (2027-2032) & (US$/MIU) Table 98. North America Urokinase Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Urokinase Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Urokinase Sales by Application (2021-2026) & (BIU) Table 101. North America Urokinase Sales by Application (2027-2032) & (BIU) Table 102. North America Urokinase Sales Price by Application (2021-2026) & (US$/MIU) Table 103. North America Urokinase Sales Price by Application (2027-2032) & (US$/MIU) Table 104. North America Urokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Urokinase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America Urokinase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America Urokinase Sales by Country (2021 VS 2025 VS 2032) & (BIU) Table 108. North America Urokinase Sales by Country (2021-2026) & (BIU) Table 109. North America Urokinase Sales by Country (2027-2032) & (BIU) Table 110. North America Urokinase Sales Price by Country (2021-2026) & (US$/MIU) Table 111. North America Urokinase Sales Price by Country (2027-2032) & (US$/MIU) Table 112. United States Urokinase Revenue (2021-2032) & (US$ Million) Table 113. Canada Urokinase Revenue (2021-2032) & (US$ Million) Table 114. Mexico Urokinase Revenue (2021-2032) & (US$ Million) Table 115. Europe Urokinase Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Urokinase Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Urokinase Sales by Type (2021-2026) & (BIU) Table 118. Europe Urokinase Sales by Type (2027-2032) & (BIU) Table 119. Europe Urokinase Sales Price by Type (2021-2026) & (US$/MIU) Table 120. Europe Urokinase Sales Price by Type (2027-2032) & (US$/MIU) Table 121. Europe Urokinase Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Urokinase Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Urokinase Sales by Application (2021-2026) & (BIU) Table 124. Europe Urokinase Sales by Application (2027-2032) & (BIU) Table 125. Europe Urokinase Sales Price by Application (2021-2026) & (US$/MIU) Table 126. Europe Urokinase Sales Price by Application (2027-2032) & (US$/MIU) Table 127. Europe Urokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Urokinase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Urokinase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Urokinase Sales by Country (2021 VS 2025 VS 2032) & (BIU) Table 131. Europe Urokinase Sales by Country (2021-2026) & (BIU) Table 132. Europe Urokinase Sales by Country (2027-2032) & (BIU) Table 133. Europe Urokinase Sales Price by Country (2021-2026) & (US$/MIU) Table 134. Europe Urokinase Sales Price by Country (2027-2032) & (US$/MIU) Table 135. Germany Urokinase Revenue (2021-2032) & (US$ Million) Table 136. France Urokinase Revenue (2021-2032) & (US$ Million) Table 137. U.K. Urokinase Revenue (2021-2032) & (US$ Million) Table 138. Italy Urokinase Revenue (2021-2032) & (US$ Million) Table 139. Russia Urokinase Revenue (2021-2032) & (US$ Million) Table 140. Spain Urokinase Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Urokinase Revenue (2021-2032) & (US$ Million) Table 142. Switzerland Urokinase Revenue (2021-2032) & (US$ Million) Table 143. Sweden Urokinase Revenue (2021-2032) & (US$ Million) Table 144. Poland Urokinase Revenue (2021-2032) & (US$ Million) Table 145. China Urokinase Revenue by Type (2021-2026) & (US$ Million) Table 146. China Urokinase Revenue by Type (2027-2032) & (US$ Million) Table 147. China Urokinase Sales by Type (2021-2026) & (BIU) Table 148. China Urokinase Sales by Type (2027-2032) & (BIU) Table 149. China Urokinase Sales Price by Type (2021-2026) & (US$/MIU) Table 150. China Urokinase Sales Price by Type (2027-2032) & (US$/MIU) Table 151. China Urokinase Revenue by Application (2021-2026) & (US$ Million) Table 152. China Urokinase Revenue by Application (2027-2032) & (US$ Million) Table 153. China Urokinase Sales by Application (2021-2026) & (BIU) Table 154. China Urokinase Sales by Application (2027-2032) & (BIU) Table 155. China Urokinase Sales Price by Application (2021-2026) & (US$/MIU) Table 156. China Urokinase Sales Price by Application (2027-2032) & (US$/MIU) Table 157. Asia Urokinase Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Urokinase Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Urokinase Sales by Type (2021-2026) & (BIU) Table 160. Asia Urokinase Sales by Type (2027-2032) & (BIU) Table 161. Asia Urokinase Sales Price by Type (2021-2026) & (US$/MIU) Table 162. Asia Urokinase Sales Price by Type (2027-2032) & (US$/MIU) Table 163. Asia Urokinase Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Urokinase Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Urokinase Sales by Application (2021-2026) & (BIU) Table 166. Asia Urokinase Sales by Application (2027-2032) & (BIU) Table 167. Asia Urokinase Sales Price by Application (2021-2026) & (US$/MIU) Table 168. Asia Urokinase Sales Price by Application (2027-2032) & (US$/MIU) Table 169. Asia Urokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Urokinase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Urokinase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Urokinase Sales by Country (2021 VS 2025 VS 2032) & (BIU) Table 173. Asia Urokinase Sales by Country (2021-2026) & (BIU) Table 174. Asia Urokinase Sales by Country (2027-2032) & (BIU) Table 175. Asia Urokinase Sales Price by Country (2021-2026) & (US$/MIU) Table 176. Asia Urokinase Sales Price by Country (2027-2032) & (US$/MIU) Table 177. Japan Urokinase Revenue (2021-2032) & (US$ Million) Table 178. South Korea Urokinase Revenue (2021-2032) & (US$ Million) Table 179. India Urokinase Revenue (2021-2032) & (US$ Million) Table 180. Australia Urokinase Revenue (2021-2032) & (US$ Million) Table 181. Taiwan Urokinase Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Urokinase Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Urokinase Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Urokinase Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Urokinase Sales by Type (2021-2026) & (BIU) Table 186. SAMEA Urokinase Sales by Type (2027-2032) & (BIU) Table 187. SAMEA Urokinase Sales Price by Type (2021-2026) & (US$/MIU) Table 188. SAMEA Urokinase Sales Price by Type (2027-2032) & (US$/MIU) Table 189. SAMEA Urokinase Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Urokinase Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Urokinase Sales by Application (2021-2026) & (BIU) Table 192. SAMEA Urokinase Sales by Application (2027-2032) & (BIU) Table 193. SAMEA Urokinase Sales Price by Application (2021-2026) & (US$/MIU) Table 194. SAMEA Urokinase Sales Price by Application (2027-2032) & (US$/MIU) Table 195. SAMEA Urokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Urokinase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Urokinase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Urokinase Sales by Country (2021 VS 2025 VS 2032) & (BIU) Table 199. SAMEA Urokinase Sales by Country (2021-2026) & (BIU) Table 200. SAMEA Urokinase Sales by Country (2027-2032) & (BIU) Table 201. SAMEA Urokinase Sales Price by Country (2021-2026) & (US$/MIU) Table 202. SAMEA Urokinase Sales Price by Country (2027-2032) & (US$/MIU) Table 203. Brazil Urokinase Revenue (2021-2032) & (US$ Million) Table 204. Argentina Urokinase Revenue (2021-2032) & (US$ Million) Table 205. Chile Urokinase Revenue (2021-2032) & (US$ Million) Table 206. Colombia Urokinase Revenue (2021-2032) & (US$ Million) Table 207. Peru Urokinase Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Urokinase Revenue (2021-2032) & (US$ Million) Table 209. Israel Urokinase Revenue (2021-2032) & (US$ Million) Table 210. UAE Urokinase Revenue (2021-2032) & (US$ Million) Table 211. Turkey Urokinase Revenue (2021-2032) & (US$ Million) Table 212. Iran Urokinase Revenue (2021-2032) & (US$ Million) Table 213. Egypt Urokinase Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Urokinase Distributors List Table 217. Urokinase Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Urokinase Image Figure 2. Global Urokinase Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urokinase Market Size Share 2021 VS 2025 VS 2032 Figure 4. Urokinase Powder Image Figure 5. Urokinase Solution Image Figure 6. Global Urokinase Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Urokinase Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Urokinase Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Urokinase Revenue (2021-2032) & (US$ Million) Figure 13. Global Urokinase Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Urokinase Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Urokinase Revenue Market Share by Region (2021-2032) Figure 16. Global Urokinase Sales (2021-2032) & (BIU) Figure 17. Global Urokinase Sales by Region: 2021 VS 2025 VS 2032 (BIU) Figure 18. Global Urokinase Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Urokinase Sales YoY (2021-2032) & (BIU) Figure 20. Europe Urokinase Sales YoY (2021-2032) & (BIU) Figure 21. China Urokinase Sales YoY (2021-2032) & (BIU) Figure 22. Asia (Excluding China) Urokinase Sales YoY (2021-2032) & (BIU) Figure 23. South America, Middle East and Africa Urokinase Sales YoY (2021-2032) & (BIU) Figure 24. Global Urokinase Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Urokinase Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Urokinase Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Urokinase Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Urokinase Revenue Market Share by Type (2021-2032) Figure 30. Global Urokinase Sales by Type (2021 VS 2025 VS 2032) & (BIU) Figure 31. Global Urokinase Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Urokinase Sales Market Share by Type (2021-2032) Figure 33. Global Urokinase Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Urokinase Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Urokinase Revenue Market Share by Application (2021-2032) Figure 36. Global Urokinase Sales by Application (2021 VS 2025 VS 2032) & (BIU) Figure 37. Global Urokinase Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Urokinase Sales Market Share by Application (2021-2032) Figure 39. North America Urokinase Revenue Share by Type (2021-2032) Figure 40. North America Urokinase Sales Share by Type (2021-2032) Figure 41. North America Urokinase Revenue Share by Application (2021-2032) Figure 42. North America Urokinase Sales Share by Application (2021-2032) Figure 43. North America Urokinase Revenue Share by Country (2021-2032) Figure 44. North America Urokinase Sales Share by Country (2021-2032) Figure 45. Europe Urokinase Revenue Share by Type (2021-2032) Figure 46. Europe Urokinase Sales Share by Type (2021-2032) Figure 47. Europe Urokinase Revenue Share by Application (2021-2032) Figure 48. Europe Urokinase Sales Share by Application (2021-2032) Figure 49. Europe Urokinase Revenue Share by Country (2021-2032) Figure 50. Europe Urokinase Sales Share by Country (2021-2032) Figure 51. China Urokinase Revenue Share by Type (2021-2032) Figure 52. China Urokinase Sales Share by Type (2021-2032) Figure 53. China Urokinase Revenue Share by Application (2021-2032) Figure 54. China Urokinase Sales Share by Application (2021-2032) Figure 55. Asia Urokinase Revenue Share by Type (2021-2032) Figure 56. Asia Urokinase Sales Share by Type (2021-2032) Figure 57. Asia Urokinase Revenue Share by Application (2021-2032) Figure 58. Asia Urokinase Sales Share by Application (2021-2032) Figure 59. Asia Urokinase Revenue Share by Country (2021-2032) Figure 60. Asia Urokinase Sales Share by Country (2021-2032) Figure 61. SAMEA Urokinase Revenue Share by Type (2021-2032) Figure 62. SAMEA Urokinase Sales Share by Type (2021-2032) Figure 63. SAMEA Urokinase Revenue Share by Application (2021-2032) Figure 64. SAMEA Urokinase Sales Share by Application (2021-2032) Figure 65. SAMEA Urokinase Revenue Share by Country (2021-2032) Figure 66. SAMEA Urokinase Sales Share by Country (2021-2032) Figure 67. Urokinase Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Urokinase Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Urokinase Powder
  • Urokinase Solution
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Syner-Med
  • Wanhua Biochem
  • Jiangxi Haoran Bio-Pharma
  • Jiangsu Aidea Pharmaceutical
  • Techpool
  • Microbic Biosystems
  • LIVZON

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Urokinase Market by Type
  3. 1.2.1 Global Urokinase Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Urokinase Powder
  5. 1.2.3 Urokinase Solution
  6. 1.3 Urokinase Market by Application
  7. 1.3.1 Global Urokinase Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Urokinase Market Dynamics
  1. 2.1 Urokinase Industry Trends
  2. 2.2 Urokinase Industry Drivers
  3. 2.3 Urokinase Industry Opportunities and Challenges
  4. 2.4 Urokinase Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Urokinase Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Urokinase Revenue by Region
  3. 3.2.1 Global Urokinase Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Urokinase Revenue by Region (2021-2026)
  5. 3.2.3 Global Urokinase Revenue by Region (2027-2032)
  6. 3.2.4 Global Urokinase Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Urokinase Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Urokinase Sales by Region
  9. 3.4.1 Global Urokinase Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Urokinase Sales by Region (2021-2026)
  11. 3.4.3 Global Urokinase Sales by Region (2027-2032)
  12. 3.4.4 Global Urokinase Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Urokinase Revenue by Manufacturers
  2. 4.1.1 Global Urokinase Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Urokinase Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Urokinase Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Urokinase Sales by Manufacturers
  6. 4.2.1 Global Urokinase Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Urokinase Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Urokinase Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Urokinase Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Urokinase Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Urokinase Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Urokinase Manufacturers, Product Type & Application
  13. 4.7 Global Urokinase Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Urokinase Market CR5 and HHI
  16. 4.8.2 2025 Urokinase Tier 1, Tier 2, and Tier 3
5 Urokinase Market by Type
  1. 5.1 Global Urokinase Revenue by Type
  2. 5.1.1 Global Urokinase Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Urokinase Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Urokinase Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Urokinase Sales by Type
  6. 5.2.1 Global Urokinase Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Urokinase Sales by Type (2021-2032) & (BIU)
  8. 5.2.3 Global Urokinase Sales Market Share by Type (2021-2032)
  9. 5.3 Global Urokinase Price by Type
6 Urokinase Market by Application
  1. 6.1 Global Urokinase Revenue by Application
  2. 6.1.1 Global Urokinase Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Urokinase Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Urokinase Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Urokinase Sales by Application
  6. 6.2.1 Global Urokinase Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Urokinase Sales by Application (2021-2032) & (BIU)
  8. 6.2.3 Global Urokinase Sales Market Share by Application (2021-2032)
  9. 6.3 Global Urokinase Price by Application
7 Company Profiles
  1. 7.1 Syner-Med
  2. 7.1.1 Syner-Med Company Information
  3. 7.1.2 Syner-Med Business Overview
  4. 7.1.3 Syner-Med Urokinase Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Syner-Med Urokinase Product Portfolio
  6. 7.1.5 Syner-Med Recent Developments
  7. 7.2 Wanhua Biochem
  8. 7.2.1 Wanhua Biochem Company Information
  9. 7.2.2 Wanhua Biochem Business Overview
  10. 7.2.3 Wanhua Biochem Urokinase Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Wanhua Biochem Urokinase Product Portfolio
  12. 7.2.5 Wanhua Biochem Recent Developments
  13. 7.3 Jiangxi Haoran Bio-Pharma
  14. 7.3.1 Jiangxi Haoran Bio-Pharma Company Information
  15. 7.3.2 Jiangxi Haoran Bio-Pharma Business Overview
  16. 7.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Jiangxi Haoran Bio-Pharma Urokinase Product Portfolio
  18. 7.3.5 Jiangxi Haoran Bio-Pharma Recent Developments
  19. 7.4 Jiangsu Aidea Pharmaceutical
  20. 7.4.1 Jiangsu Aidea Pharmaceutical Company Information
  21. 7.4.2 Jiangsu Aidea Pharmaceutical Business Overview
  22. 7.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Jiangsu Aidea Pharmaceutical Urokinase Product Portfolio
  24. 7.4.5 Jiangsu Aidea Pharmaceutical Recent Developments
  25. 7.5 Techpool
  26. 7.5.1 Techpool Company Information
  27. 7.5.2 Techpool Business Overview
  28. 7.5.3 Techpool Urokinase Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Techpool Urokinase Product Portfolio
  30. 7.5.5 Techpool Recent Developments
  31. 7.6 Microbic Biosystems
  32. 7.6.1 Microbic Biosystems Company Information
  33. 7.6.2 Microbic Biosystems Business Overview
  34. 7.6.3 Microbic Biosystems Urokinase Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Microbic Biosystems Urokinase Product Portfolio
  36. 7.6.5 Microbic Biosystems Recent Developments
  37. 7.7 LIVZON
  38. 7.7.1 LIVZON Company Information
  39. 7.7.2 LIVZON Business Overview
  40. 7.7.3 LIVZON Urokinase Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 LIVZON Urokinase Product Portfolio
  42. 7.7.5 LIVZON Recent Developments
8 North America
  1. 8.1 North America Urokinase Market Size by Type
  2. 8.1.1 North America Urokinase Revenue by Type (2021-2032)
  3. 8.1.2 North America Urokinase Sales by Type (2021-2032)
  4. 8.1.3 North America Urokinase Price by Type (2021-2032)
  5. 8.2 North America Urokinase Market Size by Application
  6. 8.2.1 North America Urokinase Revenue by Application (2021-2032)
  7. 8.2.2 North America Urokinase Sales by Application (2021-2032)
  8. 8.2.3 North America Urokinase Price by Application (2021-2032)
  9. 8.3 North America Urokinase Market Size by Country
  10. 8.3.1 North America Urokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Urokinase Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Urokinase Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Urokinase Market Size by Type
  2. 9.1.1 Europe Urokinase Revenue by Type (2021-2032)
  3. 9.1.2 Europe Urokinase Sales by Type (2021-2032)
  4. 9.1.3 Europe Urokinase Price by Type (2021-2032)
  5. 9.2 Europe Urokinase Market Size by Application
  6. 9.2.1 Europe Urokinase Revenue by Application (2021-2032)
  7. 9.2.2 Europe Urokinase Sales by Application (2021-2032)
  8. 9.2.3 Europe Urokinase Price by Application (2021-2032)
  9. 9.3 Europe Urokinase Market Size by Country
  10. 9.3.1 Europe Urokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Urokinase Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Urokinase Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Urokinase Market Size by Type
  2. 10.1.1 China Urokinase Revenue by Type (2021-2032)
  3. 10.1.2 China Urokinase Sales by Type (2021-2032)
  4. 10.1.3 China Urokinase Price by Type (2021-2032)
  5. 10.2 China Urokinase Market Size by Application
  6. 10.2.1 China Urokinase Revenue by Application (2021-2032)
  7. 10.2.2 China Urokinase Sales by Application (2021-2032)
  8. 10.2.3 China Urokinase Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Urokinase Market Size by Type
  2. 11.1.1 Asia Urokinase Revenue by Type (2021-2032)
  3. 11.1.2 Asia Urokinase Sales by Type (2021-2032)
  4. 11.1.3 Asia Urokinase Price by Type (2021-2032)
  5. 11.2 Asia Urokinase Market Size by Application
  6. 11.2.1 Asia Urokinase Revenue by Application (2021-2032)
  7. 11.2.2 Asia Urokinase Sales by Application (2021-2032)
  8. 11.2.3 Asia Urokinase Price by Application (2021-2032)
  9. 11.3 Asia Urokinase Market Size by Country
  10. 11.3.1 Asia Urokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Urokinase Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Urokinase Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Urokinase Market Size by Type
  2. 12.1.1 SAMEA Urokinase Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Urokinase Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Urokinase Price by Type (2021-2032)
  5. 12.2 SAMEA Urokinase Market Size by Application
  6. 12.2.1 SAMEA Urokinase Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Urokinase Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Urokinase Price by Application (2021-2032)
  9. 12.3 SAMEA Urokinase Market Size by Country
  10. 12.3.1 SAMEA Urokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Urokinase Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Urokinase Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Urokinase Value Chain Analysis
  2. 13.1.1 Urokinase Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Urokinase Production Mode & Process
  6. 13.2 Urokinase Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Urokinase Distributors
  9. 13.2.3 Urokinase Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst